Michigan Medicine to offer limited curbside COVID-19 screening to its patients

Note to media: To protect patient privacy and in efforts to prevent the spread of this virus, we ask that you do not visit our facilities for photos, video footage or interviews at this time. We will provide media with any available images.

Author | Beata Mostafavi

Michigan Medicine will be offering COVID-19 curbside screening for doctor-referred patients at three of its facilities.

Starting March 17, Michigan Medicine patients who have an appointment through their providers may use the screening service in the parking lots of the West Ann Arbor Health Center, Canton Health Center and Brighton Health Center.

Patients will call a hotline staffed by nurses and go through a multi-step screening process. They must be referred by physicians for curbside screening.  Those who arrive without an appointment will not be screened.

“We are offering curbside testing to help reduce the need of potentially infected patients to come inside our clinics and hospital and thus minimize the risk of COVID-19 exposure to our employees and patients,” says Michael Mulholland, M.D., Ph.D., senior associate dean for clinical affairs at Michigan Medicine and executive director of the University of Michigan Medical Group.

“Screening is not necessary for everyone. Many patients with COVID-19 have mild symptoms that can be managed at home. The first step for any concerned patient should be to call their physician before seeking treatment at a health care facility.”

Testing will be requested by Michigan Medicine providers with a focus on high-risk patients, including elderly patients and those with immuno-compromised conditions.

Patients who meet the criteria for testing will receive a swab through the window of their car. The test may either be sent to the state testing lab or a private lab and results could take several days.

“Our top priority is keeping our patients, employees and community as safe as possible during this unprecedented time,” Mulholland says.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories kidneys blue yellow
Health Lab
Why personalized medicine is important in rare kidney disease
Building a comprehensive human kidney cell and tissue catalog could help develop more treatments for kidney disease.
10 year old boy leaning against tree and posing with his mom and sisters outside
Health Lab
Family travels over 1,000 miles for son’s heart transplant
Family travels over 1,000 miles for son's heart transplant and ongoing heart care
Scientific illustration of gliobastoma cells in the brain
Health Lab
Path forward for glioblastoma treatment
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Period Poverty and the Need to Make Menstruation Products Easier to Access
A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.
Health care provider with stethoscope holds patient's hand
Health Lab
Opinion: Hospice care for those with dementia falls far short of meeting people’s needs at the end of life
An end-of-life care specialist discusses the shortfalls of hospice care coverage for people with dementia, using the experience of former President Jimmy Carter and former First Lady Rosalynn Carter as examples.
Xray of a stem cell in a mouse brain.
Health Lab
Stem cells improve memory, reduce inflammation in Alzheimer’s mouse brains
Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.